Harrington Investments, Inc Amgen Inc Transaction History

Harrington Investments, Inc

$173 Million
Q1 2024

A detailed history of Harrington Investments, Inc transactions in Amgen Inc stock. As of the latest transaction made, Harrington Investments, Inc holds 11,227 shares of AMGN stock, worth $3.61 Million. This represents 1.85% of its overall portfolio holdings.

Number of Shares

11,227

Previous 11,199 0.25%

Holding current value

$3.61 Million

Previous $3.23 Million 1.02%

% of portfolio

1.85%

Previous 2.02%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 26, 2024	BUY	$268.87 - $324.56 $7,528 - $9,087	28 Added 0.25%	11,227 $3.19 Million
Q4 2023 Jan 17, 2024	SELL	$255.7 - $288.46 $59,066 - $66,634	-231 Reduced 2.02%	11,199 $3.23 Million
Q3 2023 Oct 19, 2023	SELL	$218.65 - $271.46 $18,366 - $22,802	-84 Reduced 0.73%	11,430 $3.07 Million
Q2 2023 Jul 20, 2023	SELL	$214.27 - $253.37 $428 - $506	-2 Reduced 0.02%	11,514 $2.56 Million
Q1 2023 Apr 28, 2023	BUY	$225.79 - $275.2 $69,994 - $85,312	310 Added 2.77%	11,516 $2.78 Million

Q4 2022 Jan 11, 2023	BUY	$229.03 - $291.01 $48,325 - $61,403	211 Added 1.92%	11,206 $0
Q3 2022 Oct 19, 2022	BUY	$224.46 - $253.15 $12,345 - $13,923	55 Added 0.5%	10,995 $2.48 Million
Q2 2022 Jul 22, 2022	SELL	$230.71 - $256.74 $182,953 - $203,594	-793 Reduced 6.76%	10,940 $2.66 Million
Q1 2022 Apr 26, 2022	BUY	$219.27 - $242.57 $10,086 - $11,158	46 Added 0.39%	11,733 $2.84 Million
Q3 2021 Oct 28, 2021	SELL	$212.27 - $248.7 $11,462 - $13,429	-54 Reduced 0.46%	11,687 $2.49 Million
Q2 2021 Aug 03, 2021	BUY	$233.58 - $259.14 $46,949 - $52,087	201 Added 1.74%	11,741 $2.86 Million
Q1 2021 Apr 30, 2021	BUY	$221.91 - $258.6 $27,516 - $32,066	124 Added 1.09%	11,540 $2.87 Million
Q4 2020 Jan 13, 2021	SELL	$216.38 - $257.67 $85,253 - $101,521	-394 Reduced 3.34%	11,416 $2.63 Million
Q3 2020 Oct 21, 2020	SELL	$234.65 - $260.95 $125,303 - $139,347	-534 Reduced 4.33%	11,810 $3 Million
Q2 2020 Jul 21, 2020	SELL	$197.81 - $242.74 $5,934 - $7,282	-30 Reduced 0.24%	12,344 $2.91 Million
Q1 2020 May 07, 2020	BUY	$182.24 - $241.7 $911 - $1,208	5 Added 0.04%	12,374 $2.51 Million
Q4 2019 Feb 10, 2020	SELL	$189.21 - $243.2 $44,464 - $57,152	-235 Reduced 1.86%	12,369 $2.98 Million
Q3 2019 Nov 05, 2019	BUY	$174.11 - $208.62 $29,424 - $35,256	169 Added 1.36%	12,604 $2.44 Million
Q2 2019 Aug 07, 2019	BUY	$166.7 - $195.41 $90,851 - $106,498	545 Added 4.58%	12,435 $2.29 Million
Q1 2019 Apr 29, 2019	BUY	$180.87 - $203.88 $31,833 - $35,882	176 Added 1.5%	11,890 $2.26 Million
Q4 2018 Feb 01, 2019	SELL	$178.4 - $208.25 $23,192 - $27,072	-130 Reduced 1.1%	11,714 $2.28 Million
Q3 2018 Oct 25, 2018	SELL	$185.29 - $208.89 $18,529 - $20,889	-100 Reduced 0.84%	11,844 $2.46 Million
Q2 2018 Oct 19, 2018	SELL	$166.05 - $186.51 $36,032 - $40,472	-217 Reduced 1.78%	11,944 $2.21 Million
Q1 2018 Apr 12, 2018	SELL	$169.43 - $198.0 $346,992 - $405,504	-2,048 Reduced 14.41%	12,161 $2.07 Million
Q4 2017 Feb 01, 2018	BUY	$168.79 - $188.59 $93,172 - $104,101	552 Added 4.04%	14,209 $2.47 Million
Q3 2017 Oct 23, 2017	BUY	$167.29 - $191.0 $2.28 Million - $2.61 Million	13,657	13,657 $2.55 Million

Others Institutions Holding AMGN

# of Institutions

2,936

Shares Held

401M

Call Options Held

6.59M

Put Options Held

6.6M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $172B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Harrington Investments, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Harrington Investments, Inc with notifications on news.

Account

Harrington Investments, Inc Amgen Inc Transaction History